| 000 | 01857 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515231658.0 | ||
| 264 | 0 | _c20101207 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1573-7373 | ||
| 024 | 7 |
_a10.1007/s11060-010-0297-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPollack, Ian F | |
| 245 | 0 | 0 |
_aAkt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group. _h[electronic resource] |
| 260 |
_bJournal of neuro-oncology _cSep 2010 |
||
| 300 |
_a155-63 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBrain Neoplasms _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioma _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aLoss of Heterozygosity |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPTEN Phosphohydrolase _xgenetics |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xgenetics |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aResearch Report |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aHamilton, Ronald L | |
| 700 | 1 | _aBurger, Peter C | |
| 700 | 1 | _aBrat, Daniel J | |
| 700 | 1 | _aRosenblum, Marc K | |
| 700 | 1 | _aMurdoch, Geoffrey H | |
| 700 | 1 | _aNikiforova, Marina N | |
| 700 | 1 | _aHolmes, Emiko J | |
| 700 | 1 | _aZhou, Tianni | |
| 700 | 1 | _aCohen, Kenneth J | |
| 700 | 1 | _aJakacki, Regina I | |
| 773 | 0 |
_tJournal of neuro-oncology _gvol. 99 _gno. 2 _gp. 155-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11060-010-0297-3 _zAvailable from publisher's website |
| 999 |
_c19953657 _d19953657 |
||